• Thu, July 21, 2016
  • Fri, July 22, 2016
  • Mon, July 25, 2016
  • Tue, July 26, 2016
  • Wed, July 27, 2016

Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $385 on, Jul 21st, 2016

Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $383 to $385 on, Jul 21st, 2016.

Matthew has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Aaron Gal of "Bernstein" Initiated at Buy on, Wednesday, June 29th, 2016


Similar Stocks and Investing Publications